Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A new cell-permeable peptide allows successful allogeneic islet transplantation in mice

Abstract

Calcineurin inhibitors such as cyclosporine A and FK506 have been used for transplant therapy and treatment of autoimmune diseases. However, the inhibition of calcineurin outside the immune system has a number of side effects, including hyperglycemia. In the search for safer drugs, we developed a cell-permeable inhibitor of NFAT (nuclear factor of activated T cells) using the polyarginine peptide delivery system1,2. This peptide provided immunosuppression for fully mismatched islet allografts in mice. In addition, it did not affect insulin secretion, whereas FK506 caused a dose-dependent decrease in insulin secretion. Cell-permeable peptides can thus provide a new strategy for drug development and may eventually be useful clinically.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Transduction of 11R-peptides into Jurkat cells and inhibition of NFAT.
Figure 2: Effect of 11R-peptides on T-cell response.
Figure 3: Effect of 11R-peptides on islet transplantation.
Figure 4: Effects of FK505 and 11R-VIVIT on insulin secretion.

Similar content being viewed by others

Notes

  1. NOTE: In the version of this article originally published online, the peptide sequences in the first sentence of the Methods section, "Peptide synthesis," was printed incorrectly. The correct sequences are 11R-VIVIT, RRRRRRRRRRR-GGG-MAGPVIVITGPHEE; and 11R-VEET, RRRRRRRRRRR-GGG-MAGPPHIVEETGPHVI. The mistake has been corrected for the HTML and print versions of the article.

References

  1. Lindgren, M., Hällbrink, M., Prochiantz, A & Langel, Ü Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99–103 (2000).

    Article  CAS  Google Scholar 

  2. Schwarze, S.R. & Dowdy, S.F. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21, 45–48 (2000).

    Article  CAS  Google Scholar 

  3. Chellaiah, M.A. et al. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J. Biol. Chem. 275, 11993–20002 (2000).

    Article  CAS  Google Scholar 

  4. Dostmann, W.R. et al. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Iα inhibit NO-induced cerebral dilation. Proc. Natl. Acad. Sci. USA 97, 14772–14777 (2000).

    Article  CAS  Google Scholar 

  5. Gallouzi, I.E. & Steitz, J.A. Delineation of mRNA export pathways by the use of cell-permeable peptides. Science 294, 1895–1901 (2001).

    Article  CAS  Google Scholar 

  6. Schwarze, S.R., Ho, A., Vocero-Akbani, A. & Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569–1572 (1999).

    Article  CAS  Google Scholar 

  7. Rao, A., Luo, C. & Hogan, P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707–747 (1997).

    Article  CAS  Google Scholar 

  8. Crabtree, G.R. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 96, 611–6114 (1999).

    Article  CAS  Google Scholar 

  9. Sigal, N.H. et al. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J. Exp. Med. 173, 619–628 (1991).

    Article  CAS  Google Scholar 

  10. Platz, K.P. et al. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 58, 170–178 (1994).

    Article  CAS  Google Scholar 

  11. Pascual, M. et al. Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol. Today 19, 514–519 (1998).

    Article  CAS  Google Scholar 

  12. Hojo, M. et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397, 530–534 (1999).

    Article  CAS  Google Scholar 

  13. Aramburu, J. et al. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285, 2129–2133 (1999).

    Article  CAS  Google Scholar 

  14. Wender, P.A. et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA 97, 13003–13008 (2000).

    Article  CAS  Google Scholar 

  15. Futaki, S. et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836–5840 (2001).

    Article  CAS  Google Scholar 

  16. Matsushita, M. et al. A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J. Neurosci. 21, 6000–6007 (2001).

    Article  CAS  Google Scholar 

  17. Matsui, H., Tomizawa, K., Lu, Y.-F. & Matsushita, M. Protein therapy: in vivo protein transduction by polyarginine (11R) PTD and subcellular targeting delivery. Curr. Protein Pept Sci. 4, 151–157 (2003).

    Article  CAS  Google Scholar 

  18. Odocha, O. et al. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK506 immunosuppression. Transplant. Proc. 25, 2433–2434 (1993).

    CAS  PubMed  Google Scholar 

  19. Okitsu, T. et al. Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice. Am. J. Transplantation 1, 138–145 (2001).

    Article  CAS  Google Scholar 

  20. Redmon, J.B. et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J. Clin. Invest. 98, 2786–2793 (1996).

    Article  CAS  Google Scholar 

  21. Todt, J. et al. Repeated intratracheal challenge with particulate antigen modulates murine lung cytokines. J. Immunol. 164, 4037–4047 (2000).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank A. Rao and P. Hogan (Harvard University) for providing the GFP-NFAT-1 plasmid and other reagents; S. Bonner-Weir (Harvard University) and T. Takahashi (Tokyo University) for discussion and comments on this manuscript; and T. Ogawa and T. Shirai for technical assistance. This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (medical genome science) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Life Science Project of 21st Century, Japan, and by the Regional Research & Development Consortium Project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayuki Matsushita.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Noguchi, H., Matsushita, M., Okitsu, T. et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 10, 305–309 (2004). https://doi.org/10.1038/nm994

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm994

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing